Topamax 15 MG Oral Sprinkle Capsule
- RxCUI
- 845478
- RxNorm name
- Topamax 15 MG Oral Sprinkle Capsule
- Display name
- Topamax 15 MG Oral Sprinkle Capsule
- Full name
- Topamax 15 MG Oral Sprinkle Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topamax | TOPIRAMATE | Janssen Pharmaceuticals, Inc. | 21628112-0c47-11df-95b3-498d55d89593 | 2026-03-12 | Warnings, Adverse reactions | 845478 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 21628112-0c47-11df-95b3-498d55d89593 | Topamax 15 MG Oral Sprinkle Capsule | PSN | 30 | These highlights do not include all the information needed to use TOPAMAX ® safely and effectively. See full prescribing information for TOPAMAX ® TOPAMAX ® (topiramate) TABLETS, for oral use TOPAMAX ® (topiramate capsules) SPRINKLE CAPSULES, for oral use Initial U.S. Approval: 1996 | 20260312 |
| 21628112-0c47-11df-95b3-498d55d89593 | topiramate 15 MG Oral Capsule [Topamax] | SBD | 30 | These highlights do not include all the information needed to use TOPAMAX ® safely and effectively. See full prescribing information for TOPAMAX ® TOPAMAX ® (topiramate) TABLETS, for oral use TOPAMAX ® (topiramate capsules) SPRINKLE CAPSULES, for oral use Initial U.S. Approval: 1996 | 20260312 |
| 21628112-0c47-11df-95b3-498d55d89593 | Topamax 15 MG Oral Capsule | SY | 30 | These highlights do not include all the information needed to use TOPAMAX ® safely and effectively. See full prescribing information for TOPAMAX ® TOPAMAX ® (topiramate) TABLETS, for oral use TOPAMAX ® (topiramate capsules) SPRINKLE CAPSULES, for oral use Initial U.S. Approval: 1996 | 20260312 |